MAPT and Alzheimer disease: Indeed, cerebrospinal fluid (CSF) levels of Aβ1-42, total-tau and tau phosphorylated at threonine 181 (p-tau181) levels, mirroring cerebral amyloid, neuronal injury and tau pathology, are currently the best validated biofluid markers of AD pathology.